http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015162232-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10636948adeff7a4f9c77a5c45be2245 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2202-0275 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2016-1025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2016-0039 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2016-102 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2016-0021 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M16-009 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M16-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M16-209 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M16-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0073 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 |
| filingDate | 2015-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d714d3e4afadac72680f781543ac0054 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80428af89d06cb9aa44cb883cc1741ab http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e812650a94ab410293e6152db472f74 |
| publicationDate | 2015-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2015162232-A1 |
| titleOfInvention | Device for the treatment of, treatment of complications arising from, and/or prevention of respiratory disorders caused by bacterial, viral, protozoal, fungal and/or microbial infections, preferably for the treatment of complications arising from cystic fibrosis |
| abstract | The present invention pertains to a device (1) for the treatment of, treatment of complications arising from, and/or preventing respiratory disorders caused by bacterial, viral, protozoal, fungal and/or microbial infections, preferably for the treatment of complications arising from cystic fibrosis (CF), including a positive airway pressure device (2) for providing a breathing gas under a positive pressure to a patient interface (20), a source of nitric oxide (3) for providing gaseous nitric oxide, a gas injector (4) for injecting nitric oxide provided by the source of nitric oxide (3) into the breathing gas provided by the positive airway pressure device (2) under pressure, a flow rate sensor (5) for sensing the flow rate of the breathing gas provided to the patient interface (20) under positive airway pressure, and a controller (6) programmed for controlling the gas injector (4) for injecting the nitric oxide into the breathing gas provided by the positive airway pressure device (2) when a flow rate detected by the flow rate sensor (5) exceeds a predetermined threshold flow rate. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3703660-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017130066-A1 |
| priorityDate | 2014-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 147.